T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
Thomas E LewEdward Robert Scheffer CliffMichael DickinsonConstantine S TamJohn Francis SeymourPiers BlomberyAshish BajelDavid RitchieAmit KhotPublished in: Bone marrow transplantation (2021)